Teva Pharmaceutical's $150m three and five year loan has raised more than $300m in syndication through mandated lead arrangers Citigroup, Deutsche Bank and SMBC.
The deal pays a margin of 45bp over Libor on the three year tranche and 55bp over Libor on the five year tranche.
Three tickets are on offer: $20m for a fee of 20bp on the three year tranche and 25bp on the five year; $15m for 17.5bp or 22.5bp; and $10m for 15bp or 20bp.
